Integrated Advisors Network’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,036
Closed -$305K 760
2025
Q1
$305K Buy
7,036
+379
+6% +$19.2K 0.02% 580
2024
Q4
$374K Buy
6,657
+1,276
+24% +$79.4K 0.02% 521
2024
Q3
$367K Buy
5,381
+110
+2% +$6.21K 0.02% 551
2024
Q2
$223K Buy
5,271
+1,432
+37% +$78.8K 0.01% 637
2024
Q1
$265K Sell
3,839
-1,558
-29% -$98.5K 0.01% 623
2023
Q4
$399K Buy
5,397
+1,065
+25% +$69.8K 0.02% 492
2023
Q3
$296K Buy
4,332
+244
+6% +$20.7K 0.02% 542
2023
Q2
$384K Sell
4,088
-470
-10% -$36.7K 0.02% 496
2023
Q1
$309K Sell
4,558
-136
-3% -$8.74K 0.02% 536
2022
Q4
$232K Buy
+4,694
New +$192K 0.02% 559
2022
Q2
Sell
-3,374
Closed -$236K 683
2022
Q1
$236K Sell
3,374
-453
-12% -$33.1K 0.01% 597
2021
Q4
$298K Buy
3,827
+584
+18% +$51.5K 0.02% 530
2021
Q3
$310K Buy
+3,243
New +$342K 0.02% 505

Other funds holding EXAS

Integrated Advisors Network's EXAS Position: Q2 2025 in Review

Integrated Advisors Network sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 7,036 shares — an estimated $305K sold.

Integrated Advisors Network first reported a position in EXAS in Q3 2021 and held it in 13 quarters. The position peaked at $399K in Q4 2023. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Integrated Advisors Network reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Integrated Advisors Network sold 7,036 Exact Sciences shares in Q2 2025, an estimated $305K.
  • Integrated Advisors Network first reported a position in Exact Sciences in Q3 2021 and held it in 13 quarters.
  • Integrated Advisors Network's Exact Sciences position peaked at $399K in Q4 2023.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Integrated Advisors Network's 13F filing for Q2 2025, filed 12 Aug 2025.